Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
NPJ Breast Cancer
|
August 7, 2025
Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2- breast cancer: insights and implications
Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, et al.
ESMO Open
|
September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer
Samantha O Perakis, Sabrina Weber, Qing Zhou, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2020
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
Peter C Dubsky, Christian F Singer, Daniel Egle, et al.
Breast Cancer Research : BCR
|
December 15, 2021
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
Simon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2013
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer, Monika Artl, Martin Filipits, et al.
Wiener Klinische Wochenschrift
|
September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
Gabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Breast Cancer Research and Treatment
|
January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Breast Cancer Research and Treatment
|
May 5, 2024
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Breast (Edinburgh, Scotland)
|
February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
NPJ Breast Cancer
|
August 7, 2025
Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2- breast cancer: insights and implications
Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, et al.
ESMO Open
|
September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer
Samantha O Perakis, Sabrina Weber, Qing Zhou, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 14, 2023
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2020
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial
Peter C Dubsky, Christian F Singer, Daniel Egle, et al.
Breast Cancer Research : BCR
|
December 15, 2021
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
Simon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 7, 2013
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Ellen Heitzer, Monika Artl, Martin Filipits, et al.
Wiener Klinische Wochenschrift
|
September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
Gabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Breast Cancer Research and Treatment
|
January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Breast Cancer Research and Treatment
|
May 5, 2024
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Breast (Edinburgh, Scotland)
|
February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.
Page
of 13